BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.16% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.71% |
| 4 | Healthcare | 5.18% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
1501
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.69M | ﹤0.01% |
33,209
+22,843
| +220% | +$1.93M |
|
1502
Lamb Weston
LW
$7.34B
| $2.67M | ﹤0.01% |
44,593
-26,011
| -37% | -$1.62M |
|
1503
CALL
Clorox
CLX
$12.7B
| $2.67M | ﹤0.01% |
+192
| New | +$29.4K |
|
1504
CVR Energy
CVI
$3.56B
| $2.66M | ﹤0.01% |
104,156
-4,561
| -4% | -$94.7K |
|
1505
Hyatt Hotels
H
$17B
| $2.66M | ﹤0.01% |
27,848
+11,062
| +66% | +$1.04M |
|
1506
Texas Roadhouse
TXRH
$13.6B
| $2.65M | ﹤0.01% |
31,695
+6,954
| +28% | +$595K |
|
1507
Prosperity Bancshares
PB
$9B
| $2.65M | ﹤0.01% |
38,236
+12,833
| +51% | +$946K |
|
1508
Royal Bank of Canada
RY
$300B
| $2.65M | ﹤0.01% |
+24,010
| New | +$2.69M |
|
1509
Strategy Inc
MSTR
$37.3B
| $2.65M | ﹤0.01% |
54,400
+5,890
| +12% | +$255K |
|
1510
Smith & Nephew
SNN
$12.5B
| $2.64M | ﹤0.01% |
82,892
+62,676
| +310% | +$2.1M |
|
|
SNV
1511
DELISTED
Synovus
SNV
| $2.64M | ﹤0.01% |
53,894
-10,691
| -17% | -$541K |
|
1512
Cytokinetics
CYTK
$10.2B
| $2.62M | ﹤0.01% |
71,085
-119,655
| -63% | -$4.25M |
|
|
STOR
1513
DELISTED
STORE Capital Corporation
STOR
| $2.61M | ﹤0.01% |
89,430
-18,877
| -17% | -$582K |
|
1514
PUT
TSMC
TSM
$2.21T
| $2.61M | ﹤0.01% |
+250
| New | +$29.2K |
|
|
MRSN
1515
DELISTED
Mersana Therapeutics
MRSN
| $2.6M | ﹤0.01% |
26,105
+1,368
| +6% | +$160K |
|
|
VLRS
1516
Controladora Vuela Compania de Aviacion
VLRS
$904M
| $2.59M | ﹤0.01% |
142,510
+23,865
| +20% | +$423K |
|
1517
Portland General Electric
POR
$5.97B
| $2.59M | ﹤0.01% |
46,976
-37,293
| -44% | -$1.96M |
|
1518
LivePerson
LPSN
$35M
| $2.58M | ﹤0.01% |
7,048
+489
| +7% | +$198K |
|
1519
Bank OZK
OZK
$5.73B
| $2.58M | ﹤0.01% |
60,445
+27,942
| +86% | +$1.3M |
|
1520
iShares S&P GSCI Commodity-Indexed Trust
GSG
$939M
| $2.58M | ﹤0.01% |
113,856
+112,464
| +8,079% | +$2.31M |
|
|
PACW
1521
DELISTED
PacWest Bancorp
PACW
| $2.57M | ﹤0.01% |
59,678
-2,234
| -4% | -$105K |
|
1522
The Ensign Group
ENSG
$10.6B
| $2.57M | ﹤0.01% |
28,589
-2,869
| -9% | -$233K |
|
|
TGI
1523
DELISTED
Triumph Group
TGI
| $2.57M | ﹤0.01% |
101,589
-96,000
| -49% | -$2.13M |
|
1524
Conduent
CNDT
$241M
| $2.56M | ﹤0.01% |
496,956
-64,317
| -11% | -$316K |
|
1525
iShares MSCI USA Value Factor ETF
VLUE
$9.75B
| $2.56M | ﹤0.01% |
+24,500
| New | +$2.62M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.